NDC 0955-1729
Insulin Glargine
Insulin Glargine
Insulin Glargine is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Winthrop U.s.. The primary component is Insulin Glargine.
| Product ID | 0955-1729_a5c92d3f-d3b8-48da-9576-33a041f66dec |
| NDC | 0955-1729 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Insulin Glargine |
| Generic Name | Insulin Glargine |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2022-05-02 |
| Marketing Category | BLA / |
| Application Number | BLA021081 |
| Labeler Name | Winthrop U.S. |
| Substance Name | INSULIN GLARGINE |
| Active Ingredient Strength | 100 [iU]/mL |
| Pharm Classes | Insulin Analog [EPC], Insulin [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |